Category: Top Story
-
Eli Lilly strikes $2.75 billion drug discovery partnership with InSilico
Eli Lilly (NYSE:LLY) has entered into a drug discovery collaboration with Hong Kong-listed InSilico that could be worth up to $2.75 billion, the companies said on Sunday. As part of the agreement, InSilico will receive an upfront payment of $115 million. The company may also earn additional milestone payments that could lift the total value…
-
J&J reports one-year ICOTYDE psoriasis trial results show sustained efficacy
Johnson & Johnson (NYSE:JNJ) has released one-year results from Phase 3 clinical trials indicating that its psoriasis treatment ICOTYDE maintained strong skin clearance outcomes through 52 weeks. Data from the ICONIC-ADVANCE 1 and 2 trials showed that complete skin clearance rates improved over time. In the studies, clearance increased from 41% to 49% and from…
-
Oil climbs, futures rise as Iran war enters second month — what’s moving markets: Dow Jones, S&P, Nasdaq, Wall Street Futures
Futures tied to the major U.S. equity indices moved higher, as investors assessed the outlook for the ongoing conflict in the Middle East. Oil prices remained above $100 per barrel amid reports of U.S. troop deployments to the region and speculation that President Donald Trump is weighing a possible operation to extract uranium from Iran.…
-
BlackRock’s Fink warns AI boom could deepen inequality without wider investment access
BlackRock Inc. Chief Executive Officer Larry Fink cautioned that the rapid rise of artificial intelligence could further concentrate wealth among large corporations and investors unless more people gain access to financial markets. In his annual letter to investors, Fink said much of the wealth generated in recent decades has largely benefited those who already held…
-
Can U.S. markets absorb a $3 trillion IPO wave? Goldman weighs potential impact
A possible surge of mega initial public offerings valued at up to $3 trillion is pushing major index providers to review their inclusion rules, sparking debate over how U.S. equity markets would handle such a large influx of new listings. According to Goldman Sachs strategists, the ten largest venture-backed private companies in the United States…
-
Investors return to cash in shift echoing 2022, JPMorgan says
Investors have begun increasing their cash holdings in a move that resembles market behavior seen in 2022, as geopolitical tensions and policy uncertainty continue to weigh on sentiment, according to a research note from JPMorgan. Quantitative strategist Nikolaos Panigirtzoglou said market participants have been “abandoning equities, bonds and gold all at the same time, preferring…
-
The Market this Month | Oil Spikes, Mining Slips, and Market Signals
March markets shaped by oil volatility, metals and shifting sentiment Markets in March have been driven by sharp moves in oil, continued volatility across commodities, and early warning signals beginning to appear in broader equity markets. In this episode of Markets This Month, Anna Serin and Bruce Campbell break down what recent price action in…
-
Geopolitical Tensions and Inflation Fears Drive Broad Sell-Off on Wall Street
U.S. stocks closed sharply lower on Friday as escalating geopolitical tensions in Iran and mounting inflation concerns sent investors rushing for the exits. Crude oil prices topped $110 a barrel, amplifying worries that persistently high energy costs—compounded by ongoing tariff pressures—could slow economic growth while keeping prices elevated. The sell-off capped a bruising week for…
-
Rising Oil Prices Could Keep Pressure on Wall Street: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures indicate a weaker opening for markets on Friday, suggesting equities may continue to fall after the sharp losses recorded in the previous session. A renewed surge in crude oil prices is expected to weigh on investor sentiment, with global benchmark Brent crude climbing back above $110 per barrel after jumping more…
-
Brown-Forman and Pernod Ricard acknowledge discussions over possible merger
U.S. whiskey producer Brown-Forman (NYSE:BF.A) and French spirits group Pernod Ricard (EU:RI) said on Thursday that they are in talks about a potential combination structured as a “merger of equals.” In separate statements, the companies confirmed earlier media reports that negotiations between the two drinks makers are underway. “If agreed to and subject to customary…